Clinical Trial Update: What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI? [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update investigating the optimal antithrombotic strategy for patients with atrial fibrillation undergoing PCI.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Coronary Syndrome
• Myocardial Infarction

Snippet

Sponsor: St. Antonius Hospital | Conditions: Acute Coronary Syndrome, Myocardial Infarction | Phase 4 | Status: RECRUITING